NK3.3EV treatment produced highly significant caspase-3/7 activity in both parent ( Figure 5 e) and resistant ( Figure 5 f) K562.
← all excerpts
NK3.3-Derived Extracellular Vesicles Penetrate and Selectively Kill Treatment-Resistant Tumor Cells.
1
—
—